U.S. flag

An official website of the United States government

Display Settings:

Format

Send to:

Choose Destination
Maribavir (Livtencity): CADTH Reimbursement Recommendation: Indication: Treatment of adults with post-transplant cytomegalovirus infection/disease who are refractory (with or without genotypic resistance) to 1 or more prior antiviral therapies [Internet].

Maribavir (Livtencity): CADTH Reimbursement Recommendation: Indication: Treatment of adults with post-transplant cytomegalovirus infection/disease who are refractory (with or without genotypic resistance) to 1 or more prior antiviral therapies [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Nov.

Table of contents


Supplemental Content

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...